Slideshow

Key Concepts About Polypharmacy in Psychotic Disorders

Author(s):

Jose M. Rubio, MD

Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.

Related Videos
Julyuela/AdobeStock
Venusvi/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
Kailinin/AdobeStock
Tatiana/AdobeStock
meds pills
brain med
schizophrenia
2025
Related Content
Ronsik/AdobeStock
February 21st 2025

The Week in Review: February 17-21

Megan McSweeney
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
drug fail
February 19th 2025

What Went Wrong? Top 6 Clinical Disappointments

Leah Kuntz
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
MADNI/AdobeStock
February 17th 2025

Conference Recap: 30th Annual Nevada Psychiatric Association National Psychopharmacology Update

Megan McSweeney
schizophrenia
February 17th 2025

Xanomeline-Trospium as a Novel Agent for Treatment of Psychosis in Schizophrenia

Caitlin Leconte, MD Albert Dickan, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
© 2025 MJH Life Sciences

All rights reserved.